These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16421984)

  • 21. [Meningococcal vaccine. Editorial].
    Gendrel D; Cohen R
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S47-8. PubMed ID: 22883365
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccination against meningococcal disease: which vaccine to use?
    Bröker M
    J Travel Med; 2002; 9(3):168-9. PubMed ID: 12088587
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reminder: meningococcal vaccine.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):57. PubMed ID: 18654109
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on meningococcal C conjugate vaccines.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Apr; 31(ACS-3):1-4. PubMed ID: 15895508
    [No Abstract]   [Full Text] [Related]  

  • 27. The 2006 Childhood and Adolescent Immunization Schedule: reflections at the 50th anniversary of the polio vaccine.
    Temte JL
    Am Fam Physician; 2006 Jan; 73(1):37, 40. PubMed ID: 16417063
    [No Abstract]   [Full Text] [Related]  

  • 28. Supplementary statement on conjugate meningococcal vaccines.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2003 Sep; 29():10-1. PubMed ID: 14526693
    [No Abstract]   [Full Text] [Related]  

  • 29. Meningococcus C vaccination programme.
    Murphy JF
    Ir Med J; 2000 Sep; 93(6):164. PubMed ID: 11105434
    [No Abstract]   [Full Text] [Related]  

  • 30. Quadrivalent meningococcal conjugated vaccine: a routine or selective vaccine in Europe?
    Masuet-Aumatell C; Borrow R; Zuckerman JN
    J Infect; 2012 Sep; 65(3):193-6. PubMed ID: 22543314
    [No Abstract]   [Full Text] [Related]  

  • 31. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningococcal vaccines: a neglected topic in travel medicine?
    Wilder-Smith A
    Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine prevention of meningococcal disease: making slow progress.
    Harrison LH
    Clin Infect Dis; 2006 Dec; 43(11):1395-7. PubMed ID: 17083010
    [No Abstract]   [Full Text] [Related]  

  • 34. Monitoring the impact of the serogroup C meningococcal conjugate vaccination programme.
    Commun Dis Rep CDR Wkly; 1999 Dec; 9(49):435, 438. PubMed ID: 10598397
    [No Abstract]   [Full Text] [Related]  

  • 35. [Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands].
    de Vries M; Dankert J; Ruijs H; Timen A; de Greeff S; de Melker H
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1562-3. PubMed ID: 12212505
    [No Abstract]   [Full Text] [Related]  

  • 36. Alert on meningococcal vaccine.
    FDA Consum; 2005; 39(6):6. PubMed ID: 16669110
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization update: pertussis, meningoccocus, and human papillomavirus.
    Middleman AB
    Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [
    Boccalini S; Panatto D; Mennini FS; Marcellusi A; Bini C; Amicizia D; Lai PL; Micale RT; Frumento D; Azzari C; Ricci S; Bonito B; DI Pisa G; Iovine M; Lodi L; Giovannini M; Moscadelli A; Paoli S; Pennati BM; Pisano L; Bechini A; Bonanni P
    J Prev Med Hyg; 2021 Mar; 62(1 Suppl 1):E1-E128. PubMed ID: 34622076
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.